 ?您的位置：對(duì)照品 > 試劑耗材 > 生化試劑 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：127750 |
| 產(chǎn)品名稱：Riociguat, ≥99% |
| 產(chǎn)品CAS：625115-55-1 |
| 規(guī)格含量：5MG |
| 產(chǎn)品價(jià)格：5000 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
Riociguat, ≥99%
Product Name： Riociguat
CAS號(hào):625115-55-1
分子式:C20H19FN8O2
分子量:422.42
貯存： 儲(chǔ)存溫度-20°C
可溶性： DMSO
生化和生理學(xué)機(jī)理：
Riociguat (BAY 63-2521; BAY 632521) is a novel drug that is currently in clinical development by Bayer. Riociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH)： chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.
|
|
|
|
|
